Regulation of tissue factor and inflammatory mediators by Egr-1 in a mouse endotoxemia model.

PubWeight™: 1.11‹?› | Rank: Top 10%

🔗 View Article (PMID 12543866)

Published in Blood on January 23, 2003

Authors

Rafal Pawlinski1, Brian Pedersen, Bettina Kehrle, William C Aird, Rolf D Frank, Mausumee Guha, Nigel Mackman

Author Affiliations

1: Department of Immunology, The Scripps Research Institute, La Jolla, CA, USA.

Articles citing this

Hematopoietic and nonhematopoietic cell tissue factor activates the coagulation cascade in endotoxemic mice. Blood (2010) 2.10

Spatial localization of bacteria controls coagulation of human blood by 'quorum acting'. Nat Chem Biol (2008) 1.74

Early growth response-1 transcription factor is essential for ethanol-induced fatty liver injury in mice. Gastroenterology (2005) 1.45

Tissue factor-dependent coagulation is preferentially up-regulated within arterial branching areas in a baboon model of Escherichia coli sepsis. Am J Pathol (2005) 1.37

TNF-α signalling and inflammation: interactions between old acquaintances. Inflamm Res (2013) 1.16

Cellular sources of tissue factor in endotoxemia and sepsis. Thromb Res (2010) 1.09

Role of tissue factor in venous thrombosis. Annu Rev Physiol (2011) 1.09

Transcription factor early growth response-1 induction mediates inflammatory gene expression and brain damage following transient focal ischemia. J Neurochem (2008) 1.07

Hepatic fibrosis is enhanced and accompanied by robust oval cell activation after chronic carbon tetrachloride administration to Egr-1-deficient mice. Am J Pathol (2010) 1.00

Proinflammatory role of leukocyte-derived Egr-1 in the development of murine postoperative ileus. Gastroenterology (2008) 0.97

Construction and validation of a Bovine Innate Immune Microarray. BMC Genomics (2005) 0.95

Venous thromboembolism in malignant gliomas. J Thromb Haemost (2009) 0.92

Sepsis-associated disseminated intravascular coagulation and thromboembolic disease. Mediterr J Hematol Infect Dis (2010) 0.91

The P2X7-Egr pathway regulates nucleotide-dependent inflammatory gene expression in microglia. Glia (2010) 0.91

Rcan1 negatively regulates Fc epsilonRI-mediated signaling and mast cell function. J Exp Med (2009) 0.89

Global transcriptional response of macrophage-like THP-1 cells to Shiga toxin type 1. Infect Immun (2010) 0.86

Regulation of cytokine and chemokine expression by the ribotoxic stress response elicited by Shiga toxin type 1 in human macrophage-like THP-1 cells. Infect Immun (2012) 0.86

Role of alveolar epithelial early growth response-1 (Egr-1) in CD8+ T cell-mediated lung injury. Mol Immunol (2009) 0.86

Regulation of tissue factor gene expression in monocytes and endothelial cells: Thromboxane A2 as a new player. Vascul Pharmacol (2014) 0.85

Expression of Egr-1, c-fos and cyclin D1 in esophageal cancer and its precursors: An immunohistochemical and in situ hybridization study. World J Gastroenterol (2004) 0.82

Endothelial cell control of thrombosis. BMC Cardiovasc Disord (2015) 0.80

Time-dependent expression and distribution of Egr-1 during skeletal muscle wound healing in rats. J Mol Histol (2012) 0.79

Overexpression of Notch1 ectodomain in myeloid cells induces vascular malformations through a paracrine pathway. Am J Pathol (2007) 0.77

Distinct signalling pathways of murine histamine H1- and H4-receptors expressed at comparable levels in HEK293 cells. PLoS One (2014) 0.75

The Host Cell Transcription Factor EGR1 Is Induced by Bacteria through the EGFR-ERK1/2 Pathway. Front Cell Infect Microbiol (2017) 0.75

Articles by these authors

HIF-1alpha is essential for myeloid cell-mediated inflammation. Cell (2003) 9.12

The phosphatidylinositol 3-kinase-Akt pathway limits lipopolysaccharide activation of signaling pathways and expression of inflammatory mediators in human monocytic cells. J Biol Chem (2002) 4.28

Down's syndrome suppression of tumour growth and the role of the calcineurin inhibitor DSCR1. Nature (2009) 3.93

Monocytes, neutrophils, and platelets cooperate to initiate and propagate venous thrombosis in mice in vivo. J Exp Med (2012) 3.63

Endotoxemia and sepsis mortality reduction by non-anticoagulant activated protein C. J Exp Med (2007) 3.35

Macrovascular thrombosis is driven by tissue factor derived primarily from the blood vessel wall. Blood (2004) 3.31

Vascular endothelial growth factor is an important determinant of sepsis morbidity and mortality. J Exp Med (2006) 2.75

The Akt-regulated forkhead transcription factor FOXO3a controls endothelial cell viability through modulation of the caspase-8 inhibitor FLIP. J Biol Chem (2003) 2.51

Oncogenic events regulate tissue factor expression in colorectal cancer cells: implications for tumor progression and angiogenesis. Blood (2004) 2.41

Protein disulfide isomerase acts as an injury response signal that enhances fibrin generation via tissue factor activation. J Clin Invest (2008) 2.39

Signal-dependent splicing of tissue factor pre-mRNA modulates the thrombogenicity of human platelets. J Exp Med (2006) 2.39

TLR2 is constitutively expressed within the kidney and participates in ischemic renal injury through both MyD88-dependent and -independent pathways. J Immunol (2007) 2.32

Microparticles in hemostasis and thrombosis. Circ Res (2011) 2.26

Role of tissue factor and protease-activated receptors in a mouse model of endotoxemia. Blood (2003) 2.20

Hematopoietic cell-derived microparticle tissue factor contributes to fibrin formation during thrombus propagation. Blood (2004) 2.16

High glucose-induced expression of proinflammatory cytokine and chemokine genes in monocytic cells. Diabetes (2003) 2.14

Hematopoietic and nonhematopoietic cell tissue factor activates the coagulation cascade in endotoxemic mice. Blood (2010) 2.10

Del-1, an endogenous leukocyte-endothelial adhesion inhibitor, limits inflammatory cell recruitment. Science (2008) 2.10

Vascular endothelial growth factor- and thrombin-induced termination factor, Down syndrome critical region-1, attenuates endothelial cell proliferation and angiogenesis. J Biol Chem (2004) 2.05

The thrombomodulin-protein C system is essential for the maintenance of pregnancy. Nat Med (2003) 1.98

Protease-activated receptor-1 contributes to cardiac remodeling and hypertrophy. Circulation (2007) 1.97

Vascular endothelial growth factor activates PI3K/Akt/forkhead signaling in endothelial cells. Arterioscler Thromb Vasc Biol (2003) 1.95

Role of tissue factor in cancer. J Clin Oncol (2009) 1.91

Regulation of tissue factor--mediated initiation of the coagulation cascade by cell surface grp78. Arterioscler Thromb Vasc Biol (2005) 1.82

Genetic analysis of the role of the PI3K-Akt pathway in lipopolysaccharide-induced cytokine and tissue factor gene expression in monocytes/macrophages. J Immunol (2008) 1.74

Ets motifs are necessary for endothelial cell-specific expression of a 723-bp Tie-2 promoter/enhancer in Hprt targeted transgenic mice. Arterioscler Thromb Vasc Biol (2003) 1.72

The association of endothelial cell signaling, severity of illness, and organ dysfunction in sepsis. Crit Care (2010) 1.72

Vascular endothelial growth factor activation of endothelial cells is mediated by early growth response-3. Blood (2009) 1.68

PPAR activators as antiinflammatory mediators in human T lymphocytes: implications for atherosclerosis and transplantation-associated arteriosclerosis. Circ Res (2002) 1.66

PI3K-Akt pathway suppresses coagulation and inflammation in endotoxemic mice. Arterioscler Thromb Vasc Biol (2004) 1.65

Selective Kv1.3 channel blocker as therapeutic for obesity and insulin resistance. Proc Natl Acad Sci U S A (2013) 1.64

Endothelial cell activation in emergency department patients with sepsis-related and non-sepsis-related hypotension. Shock (2011) 1.61

Chlamydia pneumoniae induces tissue factor expression in mouse macrophages via activation of Egr-1 and the MEK-ERK1/2 pathway. Circ Res (2003) 1.59

Factor Xa binding to annexin 2 mediates signal transduction via protease-activated receptor 1. Circ Res (2008) 1.55

Differential contribution of FXa and thrombin to vascular inflammation in a mouse model of sickle cell disease. Blood (2014) 1.53

Monocyte tissue factor-dependent activation of coagulation in hypercholesterolemic mice and monkeys is inhibited by simvastatin. J Clin Invest (2012) 1.51

Protease-activated receptor-2 regulates the innate immune response to viral infection in a coxsackievirus B3-induced myocarditis. J Am Coll Cardiol (2013) 1.50

Tissue factor: a link between C5a and neutrophil activation in antiphospholipid antibody induced fetal injury. Blood (2007) 1.49

Monocytic microparticles activate endothelial cells in an IL-1β-dependent manner. Blood (2011) 1.48

PF4/heparin-antibody complex induces monocyte tissue factor expression and release of tissue factor positive microparticles by activation of FcγRI. Blood (2012) 1.48

A prospective, observational study of soluble FLT-1 and vascular endothelial growth factor in sepsis. Shock (2008) 1.47

Vascular heterogeneity in the kidney. Semin Nephrol (2012) 1.46

Critical review of mouse models of venous thrombosis. Arterioscler Thromb Vasc Biol (2012) 1.46

Role of RNA splicing in mediating lineage-specific expression of the von Willebrand factor gene in the endothelium. Blood (2013) 1.45

Drug Repurposing Screen Identifies Foxo1-Dependent Angiopoietin-2 Regulation in Sepsis. Crit Care Med (2015) 1.45

Increased microparticle tissue factor activity in cancer patients with Venous Thromboembolism. Thromb Res (2009) 1.43

Lipopolysaccharide-induced heme oxygenase-1 expression in human monocytic cells is mediated via Nrf2 and protein kinase C. J Immunol (2005) 1.36

NADPH oxidase activity selectively modulates vascular endothelial growth factor signaling pathways. J Biol Chem (2007) 1.34

Tissue factor-positive neutrophils bind to injured endothelial wall and initiate thrombus formation. Blood (2012) 1.34

Vascular smooth muscle-derived tissue factor is critical for arterial thrombosis after ferric chloride-induced injury. Blood (2008) 1.32

Thrombin and phenotypic modulation of the endothelium. Arterioscler Thromb Vasc Biol (2003) 1.31

Endothelial cell gene regulation. Trends Cardiovasc Med (2005) 1.29

Forkhead transcription factors inhibit vascular smooth muscle cell proliferation and neointimal hyperplasia. J Biol Chem (2005) 1.28

Role of tissue factor in haemostasis, thrombosis, angiogenesis and inflammation: lessons from low tissue factor mice. Thromb Haemost (2004) 1.28

Thrombin-induced autoinhibitory factor, Down syndrome critical region-1, attenuates NFAT-dependent vascular cell adhesion molecule-1 expression and inflammation in the endothelium. J Biol Chem (2006) 1.27

A balance between tissue factor and tissue factor pathway inhibitor is required for embryonic development and hemostasis in adult mice. Blood (2004) 1.26

Antiinflammatory effects of the ETS factor ERG in endothelial cells are mediated through transcriptional repression of the interleukin-8 gene. Circ Res (2009) 1.25

Platelet ITAM signaling is critical for vascular integrity in inflammation. J Clin Invest (2013) 1.24

Neutrophil activation by the tissue factor/Factor VIIa/PAR2 axis mediates fetal death in a mouse model of antiphospholipid syndrome. J Clin Invest (2008) 1.23

Role of the coagulation system in acetaminophen-induced hepatotoxicity in mice. Hepatology (2007) 1.23

Vascular endocan is preferentially expressed in tumor endothelium. Microvasc Res (2006) 1.22

Epidermal growth factor receptor and PTEN modulate tissue factor expression in glioblastoma through JunD/activator protein-1 transcriptional activity. Cancer Res (2009) 1.22

Mechanisms of endothelial cell heterogeneity in health and disease. Circ Res (2006) 1.21

Tissue factor in hemostasis and thrombosis. Semin Thromb Hemost (2006) 1.21

Tumor-derived tissue factor activates coagulation and enhances thrombosis in a mouse xenograft model of human pancreatic cancer. Blood (2012) 1.20

Vascular endothelial growth factor-mediated induction of manganese superoxide dismutase occurs through redox-dependent regulation of forkhead and IkappaB/NF-kappaB. J Biol Chem (2004) 1.20

Tissue factor regulation by epidermal growth factor receptor and epithelial-to-mesenchymal transitions: effect on tumor initiation and angiogenesis. Cancer Res (2008) 1.19

Tumor-derived tissue factor-positive microparticles and venous thrombosis in cancer patients. Blood (2013) 1.19

Biomarkers of endothelial cell activation in early sepsis. Shock (2013) 1.18

Factor XIII activity mediates red blood cell retention in venous thrombi. J Clin Invest (2014) 1.18

Tissue factor deficiency and PAR-1 deficiency are protective against renal ischemia reperfusion injury. Blood (2006) 1.18

A three-kilobase fragment of the human Robo4 promoter directs cell type-specific expression in endothelium. Circ Res (2007) 1.17

Tissue factor and its measurement in whole blood, plasma, and microparticles. Semin Thromb Hemost (2010) 1.17

Oncogenes, trousseau syndrome, and cancer-related changes in the coagulome of mice and humans. Cancer Res (2006) 1.16

Tissue factor and thrombosis: The clot starts here. Thromb Haemost (2010) 1.16

COX-2 suppresses tissue factor expression via endocannabinoid-directed PPARdelta activation. J Exp Med (2007) 1.16

Platelet-endothelial interactions: sepsis, HIT, and antiphospholipid syndrome. Hematology Am Soc Hematol Educ Program (2003) 1.15

Histone deacetylase inhibitor reduces monocyte adhesion to endothelium through the suppression of vascular cell adhesion molecule-1 expression. Arterioscler Thromb Vasc Biol (2006) 1.14

Early growth response gene-1 regulates hypoxia-induced expression of tissue factor in glioblastoma multiforme through hypoxia-inducible factor-1-independent mechanisms. Cancer Res (2006) 1.13

CpG oligodeoxynucleotide protection in polymicrobial sepsis is dependent on interleukin-17. J Infect Dis (2005) 1.12

Tissue factor, coagulation proteases, and protease-activated receptors in endotoxemia and sepsis. Crit Care Med (2004) 1.12

Thrombin stimulation of vascular adhesion molecule-1 in endothelial cells is mediated by protein kinase C (PKC)-delta-NF-kappa B and PKC-zeta-GATA signaling pathways. J Biol Chem (2002) 1.12

ETS-related gene (ERG) controls endothelial cell permeability via transcriptional regulation of the claudin 5 (CLDN5) gene. J Biol Chem (2012) 1.11

Induction of tissue factor expression in human endothelial cells by CD40 ligand is mediated via activator protein 1, nuclear factor kappa B, and Egr-1. J Biol Chem (2002) 1.11

A novel class of vascular endothelial growth factor-responsive genes that require forkhead activity for expression. J Biol Chem (2006) 1.10

Interaction between hex and GATA transcription factors in vascular endothelial cells inhibits flk-1/KDR-mediated vascular endothelial growth factor signaling. J Biol Chem (2004) 1.09

PAR-1 contributes to the innate immune response during viral infection. J Clin Invest (2013) 1.09

Phenotypic heterogeneity is an evolutionarily conserved feature of the endothelium. Blood (2006) 1.09

Cellular sources of tissue factor in endotoxemia and sepsis. Thromb Res (2010) 1.09

Role of tissue factor in venous thrombosis. Annu Rev Physiol (2011) 1.09

Transcriptional regulation of EGR-1 by the interleukin-1-JNK-MKK7-c-Jun pathway. J Biol Chem (2008) 1.08

Contribution of host-derived tissue factor to tumor neovascularization. Arterioscler Thromb Vasc Biol (2008) 1.08

Insulin activation of the phosphatidylinositol 3-kinase/protein kinase B (Akt) pathway reduces lipopolysaccharide-induced inflammation in mice. J Pharmacol Exp Ther (2008) 1.07

Identifying patients at high risk of a cardiovascular event in the near future: current status and future directions: report of a national heart, lung, and blood institute working group. Circulation (2010) 1.07